TCL Archive Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent By Cancer History Project September 30, 2011
TCL Archive Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University By Cancer History Project September 30, 2011
TCL Archive NKTR-102 Shows 29 Percent Response in Phase II Study By Cancer History Project September 30, 2011
TCL Archive Kulig Will Oversee Outcomes Research at NCCN By Cancer History Project September 30, 2011
TCL Archive New Two-Step Matching Process Increases Success of Transplants By Cancer History Project September 30, 2011
TCL Archive Weak Electromagnetic Fields Can Possibly Stabilize Tumors By Cancer History Project September 30, 2011
TCL Archive One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent By Cancer History Project September 30, 2011
TCL Archive Neurocognitive Deficits Affect Future Adult Employment By Cancer History Project September 30, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
